Join the Crohn's Disease - Acute group to help and get support from people like you.
Crohn's Disease - Acute News (Page 2)
Subtle Changes Could Predict Inflammatory Bowel Disease Years Before Symptoms Hit
MONDAY, Nov. 13, 2023 (Healthday News) – Inflammatory bowel disease starts to develop years before patients come down with symptoms, a new study suggests. Gut changes can be detected in blood tests...
Inflammatory Bowel Disease Increases Risk for Later Arrhythmias
MONDAY, Nov. 6, 2023 – Patients with inflammatory bowel disease (IBD) overall, as well as Crohn disease (CD) and ulcerative colitis (UC) individually, have an increased risk for developing later...
ACG: Prophylactic Low-Dose Aspirin in Pregnancy Does Not Increase IBD Activity
THURSDAY, Oct. 26, 2023 – Use of low-dose aspirin (LDA) among pregnant women with inflammatory bowel disease (IBD) is not associated with an increased risk for disease activity, according to a study...
Inflammatory Bowel Disease Tied to Higher Risk for Gout
TUESDAY, Oct. 3, 2023 – Inflammatory bowel disease (IBD) is strongly associated with gout, according to a study published online Sept. 1 in JGH Open. Osama Hamid, M.B.B.S., from the Cleveland...
AI-Based Radiomic Model Improves Diagnosis of Crohn Disease
THURSDAY, Aug. 10, 2023 – In a study published Aug. 2 in the American Journal of Roentgenology, a radiomic machine learning model predicted Crohn's disease diagnosis with better performance than two...
Higher Belly Fat Percentage Tied to Worse Outcomes for IBD Patients
WEDNESDAY, Aug. 2, 2023 – For patients with inflammatory bowel disease (IBD), higher intra-abdominal visceral adipose tissue (IA-VAT) as a percentage of total body mass is associated with worse...
Belly Fat Can Hamper Effectiveness of Meds for Crohn's, Colitis
MONDAY, July 31, 2023 – Some medications may not treat inflammatory bowel disease (IBD) as effectively if patients carry a lot of excess belly fat, , new research shows. IBD includes illnesses such...
FDA Approves Abrilada (adalimumab-afzb), a Biosimilar to Humira
November 18, 2019 - Pfizer Inc. (NYSE: PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved Abrilada™ (adalimumab-afzb), as a biosimilar to Humira® (a...
FDA Approves Ixifi (infliximab-qbtx), a Biosimilar to Remicade
December 13, 2017 – Pfizer Inc. (NYSE:PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved Ixifi (PF-06438179, infliximab-qbtx), a chimeric...
FDA Approves Cyltezo (adalimumab-adbm), a Biosimilar to Humira
Ridgefield, Conn., August 29, 2017 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Cyltezo, a biosimilar to Humira, in a p...
FDA Approves Renflexis (infliximab-abda), a Biosimilar to Remicade
INCHEON, Korea – April 24, 2017 – Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved Renflexis (infliximab-abda), a biosimilar referencing Rem...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
prednisone, metronidazole, Humira, ciprofloxacin, betamethasone, hydrocortisone, cortisone, Remicade, prednisolone, Stelara, adalimumab, dexamethasone, budesonide